Skip to main content

MoneyWorks4Me

Colinz Laboratories - Quaterly Results

30 Oct 2026 Evaluate
The September 2026 quarter revenue stood at Rs. 15.50 millions, up 11.67% as compared to Rs. 13.88 millions during the corresponding quarter last year.Net profit declined -10.00% to Rs. 1.26 millions from Rs. 1.40 millions.The Operating Profit of the company witnessed a decrease to 2.21 millions from 2.38 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 15.50 13.88 11.67 27.91 29.54 -5.52 61.36 65.28 -6.00
Other Income 1.39 1.59 -12.58 2.61 2.34 11.54 4.84 2.98 62.42
PBIDT 2.21 2.38 -7.14 4.05 4.49 -9.80 8.91 7.94 12.22
Interest 0.16 0.13 23.08 0.23 0.25 -8.00 0.47 0.42 11.90
PBDT 2.05 2.25 -8.89 31.45 4.24 641.75 8.44 7.52 12.23
Depreciation 0.19 0.39 -51.28 0.58 0.78 -25.64 1.56 1.31 19.08
PBT 1.86 1.86 0.00 30.87 3.46 792.20 6.88 6.21 10.79
TAX 0.60 0.46 30.43 5.60 0.88 536.36 1.75 1.23 42.28
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.15 -0.52 -71.15
PAT 1.26 1.40 -10.00 25.27 2.58 879.46 5.13 4.98 3.01
Equity 25.19 25.19 0.00 25.19 25.19 0.00 25.19 25.19 0.00
PBIDTM(%) 14.26 17.15 -16.85 14.51 15.20 -4.53 14.52 12.16 19.39
Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..